dichlororibofuranosylbenzimidazole has been researched along with Hypertension, Pulmonary in 1 studies
Dichlororibofuranosylbenzimidazole: An RNA polymerase II transcriptional inhibitor. This compound terminates transcription prematurely by selective inhibition of RNA synthesis. It is used in research to study underlying mechanisms of cellular regulation.
Hypertension, Pulmonary: Increased VASCULAR RESISTANCE in the PULMONARY CIRCULATION, usually secondary to HEART DISEASES or LUNG DISEASES.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lee, JE | 1 |
| Yang, YM | 1 |
| Liang, FX | 1 |
| Gough, DJ | 1 |
| Levy, DE | 1 |
| Sehgal, PB | 1 |
1 other study available for dichlororibofuranosylbenzimidazole and Hypertension, Pulmonary
| Article | Year |
|---|---|
Nongenomic STAT5-dependent effects on Golgi apparatus and endoplasmic reticulum structure and function.
Topics: Animals; Cattle; Cell Nucleus; Cells, Cultured; Centrosome; Cytoplasm; Dichlororibofuranosylbenzimid | 2012 |